|
Volumn 3, Issue 7, 2015, Pages 503-504
|
The challenges of treating Ebola virus disease with experimental therapies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ELECTROLYTE;
FAVIPIRAVIR;
ACUTE LUNG INJURY;
CONVALESCENCE;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SAFETY;
EBOLA HEMORRHAGIC FEVER;
EBOLAVIRUS;
FINANCIAL MANAGEMENT;
FLUID THERAPY;
HUMAN;
NOTE;
PATIENT CARE;
PLASMA TRANSFUSION;
POSITIVE END EXPIRATORY PRESSURE;
PRIORITY JOURNAL;
RESPIRATORY FAILURE;
THYROID DISEASE;
TREATMENT PLANNING;
FEMALE;
HEMORRHAGIC FEVER, EBOLA;
NURSING ASSISTANT;
OCCUPATIONAL DISEASES;
PLASMA;
RESPIRATORY DISTRESS SYNDROME, ADULT;
FEMALE;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
NURSES' AIDES;
OCCUPATIONAL DISEASES;
PLASMA;
RESPIRATORY DISTRESS SYNDROME, ADULT;
|
EID: 84943193218
PISSN: 22132600
EISSN: 22132619
Source Type: Journal
DOI: 10.1016/S2213-2600(15)00237-4 Document Type: Note |
Times cited : (1)
|
References (11)
|